...有更强的体外杀伤作用,CD3AK/iNOS可能成为一个更有效的自体造血干细胞移植(autologous hematopoietic stem cell transplantation,AHSCT)体外净化方法。
基于2个网页-相关网页
来那度胺适应症扩展后，成为FDA批准的第一个也是唯一的用于自体造血干细胞移植后维持治疗的药物。
The expanded indication makes lenalidomide the first and only treatment to receive FDA approval for maintenance use following autologous hematopoietic stem cell transplant.
目的：评价自体造血干细胞移植对急性髓系白血病的改善效果。
OBJECTIVE: to evaluate effect of autologous hematopoietic stem cell transplantation on the treatment of acute AML.
自体外周血造血干细胞（PBSC）移植后血液系统的重建与采集和保存的PBSC的质量和数量有密切关系。
The quality and quantity of peripheral blood stem cells (PBSC) are considered as an essential factor for short term and long term hematopoietic reconstruction after PBSC autograft.
应用推荐